BBOX1 promotes triple-negative breast cancer progression by controlling IP3R3 stability

被引:4
|
作者
Liao, Chengheng [1 ]
Zhang, Qing [1 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
关键词
TNBC; 2-OG dependent enzyme; therapeutic target;
D O I
10.1080/23723556.2020.1813526
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Limited therapeutic options impede the clinical outcome of triple-negative breast cancer (TNBC). Our recent study uncovered a novel signaling pathway implicating gamma-butyrobetaine hydroxylase 1 (BBOX1) in the control of cell growth in TNBC, via inositol 1, 4, 5-trisphosphate receptor type 3 (IP3R3) mediated calcium signaling which is essential for cellular energy metabolism.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Identification of BBOX1 as a therapeutic target in triple-negative breast cancer
    Liao, Chengheng
    Zhang, Yang
    Fan, Cheng
    Herring, Laura E.
    Liu, Juan
    Locasale, Jason W.
    Takada, Mamoru
    Zhou, Jin
    Zurlo, Giada
    Hu, Lianxin
    Simon, Jeremy M.
    Ptacek, Travis S.
    Andrianov, Victor G.
    Loza, Einars
    Peng, Yan
    Yang, Huanghe
    Perou, Charles M.
    Zhang, Qing
    CANCER RESEARCH, 2021, 81 (04)
  • [2] Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer
    Liao, Chengheng
    Zhang, Yang
    Fan, Cheng
    Herring, Laura E.
    Liu, Juan
    Locasale, Jason W.
    Takada, Mamoru
    Zhou, Jin
    Zurlo, Giada
    Hu, Lianxin
    Simon, Jeremy M.
    Ptacek, Travis S.
    Andrianov, Victor G.
    Loza, Einars
    Peng, Yan
    Yang, Huanghe
    Perou, Charles M.
    Zhang, Qing
    CANCER DISCOVERY, 2020, 10 (11) : 1706 - 1721
  • [3] Breast Cancer Antiestrogen Resistance 3 (BCAR3) promotes tumor growth and progression in triple-negative breast cancer
    Arras, Janet
    Thomas, Keena S.
    Myers, Paul J.
    Cross, Allison M.
    Osei, Amare D.
    Vazquez, Gabriel E.
    Atkins, Kristen A.
    Conaway, Mark R.
    Jones, Marieke K.
    Lazzara, Matthew J.
    Bouton, Amy H.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (10): : 4768 - 4787
  • [4] PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression
    Gagliano, Teresa
    Shah, Kalpit
    Gargani, Sofia
    Lao, Liyan
    Alsaleem, Mansour
    Chen, Jianing
    Ntafis, Vasileios
    Huang, Penghan
    Ditsiou, Angeliki
    Vella, Viviana
    Yadav, Kritika
    Bienkowska, Kamila
    Bresciani, Giulia
    Kang, Kai
    Li, Leping
    Carter, Philip
    Benstead-Hume, Graeme
    O'Hanlon, Timothy
    Dean, Michael
    Pearl, Frances M. G.
    Lee, Soo-Chin
    Rakha, Emad A.
    Green, Andrew R.
    Kontoyiannis, Dimitris L.
    Song, Erwei
    Stebbing, Justin
    Giamas, Georgios
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (06): : 3188 - 3204
  • [5] Acetylation of Checkpoint suppressor 1 enhances its stability and promotes the progression of triple-negative breast cancer
    Xu, Zhaowei
    Liu, Shuyan
    Feng, Chun
    Xu, Fuyi
    Kong, Demin
    Mi, Jia
    Yang, Chunhua
    Zhang, Guilong
    Wei, Pengfei
    Orgil, Buyan-Ochir
    Bergquist, Jonas
    Tian, Geng
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [6] Acetylation of Checkpoint suppressor 1 enhances its stability and promotes the progression of triple-negative breast cancer
    Zhaowei Xu
    Shuyan Liu
    Chun Feng
    Fuyi Xu
    Demin Kong
    Jia Mi
    Chunhua Yang
    Guilong Zhang
    Pengfei Wei
    Buyan-Ochir Orgil
    Jonas Bergquist
    Geng Tian
    Cell Death Discovery, 8
  • [7] ETS1 is a prognostic biomarker of triple-negative breast cancer and promotes the triple-negative breast cancer progression through the YAP signaling
    Li, Yanlin
    Wu, Tiantian
    Peng, Ziluo
    Tian, Xianyan
    Dai, Qian
    Chen, Miao
    Zhu, Jun
    Xia, Song
    Sun, Aiqin
    Yang, Wannian
    Lin, Qiong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (11): : 5074 - 5084
  • [8] SEPTIN3 Promotes Progression of Triple-Negative Breast Cancer via Activating Wnt Pathway
    Wang, Guo-Zhou
    Yang, Li-Hua
    Gao, Chao
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 4155 - 4164
  • [9] SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer
    Zhu, Youzhi
    Zhang, Jiasheng
    Yu, Liangfei
    Xu, Sunwang
    Chen, Ling
    Wu, Kunlin
    Kong, Lingjun
    Lin, Wei
    Xue, Jiajie
    Wang, Qingshui
    Lin, Yao
    Chen, Xiangjin
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [10] MYCL promotes the progression of triple-negative breast cancer by activating the JAK/STAT3 pathway
    Jiang, Hongnan
    Li, Xiaojun
    Wang, Wei
    Hu, Yaofeng
    Ren, Dongliang
    ONCOLOGY REPORTS, 2022, 48 (05)